Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
We have surveyed the incidence of adult T‐cell leukemia/lymphoma (ATLL) in an endemic area of 290,464 inhabitants for 7 years. We now revise our previous results on the basis of additional findings and estimate the age‐ and sex‐specific cumulative rate for HTLV‐I carriers, the adoption of which is recommended by current cancer epidemiology as a new age‐standardized incidence rate. An unequivocal age‐dependent increase in seroprevalence was observed for both sexes with a characteristic predominance in females. The age‐dependent seroconversion in females may be partly explained by additional infection from infected husbands to their wives but the reason for men remains obscure. The mean annual number of incident cases of ATLL was 11.4, giving 3.9 ATLL patients annually per 10 5 inhabitants, 6.1 per 10 5 inhabitants aged over 30, and 85.0 per 10 5 seropositives aged over 30. Crude annual incidence rate of ATLL among 10 5 male seropositives aged over 30 was 145.3 and that for females was 55.2 and 95% confidence intervals of ATLL incidence rates were 34.8 to 255.7 for males and 6.4 to 104.1 for females, respectively. Although the sex ratio of 80 ATLL patients was 1.35, males are more prone to the disease (46 male patients among 4,522 male seropositives aged over 30 vs. 34 female patients among 8,801 female seropositives aged over 30; p < 0.001) for unknown reason(s). Morbidity in male seropositives aged over 30 is 2.6 times as high as that of females. Decennial incidence rates in males in their fifties and sixties were significantly higher than those in females. The remarkable male preponderance in oncogenicity of HTLV‐I may be due to the fact that men are more prone to the disease and the number of female carriers in the denominator used to calculate the incidence rate is larger than that of males. The whole life span (0–79) cumulative risk for males was 6.9% and significantly higher than that of females (2.95%).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Approximately 5% of HTLV-1 patients are at risk of developing ATL, an aggressive mature T cell malignancy [104,191].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [191]
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Hinuma, Y., Komoda, H., Chosa, T., Kondo, T., Kohakura, M., Takenaka, T., Kikuchi, M., Ichimaru, M., Yunoki, K., Sato, I., et al. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290606 · Cited by 591
Self-citationIntrafamilial Transmission of Adult T Cell Leukemia Virus
Kajiyama, W., Kashiwagi, S., Ikematsu, H., Hayashi, J., Nomura, H., & Okochi, K. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.5.851 · Cited by 314
Maeda, Y., Furukawa, M., Takehara, Y., Yoshimura, K., Miyamoto, K., Matsuura, T., Morishima, Y., Tajima, K., Okochi, K., & Hinuma, Y. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330602 · Cited by 136
Self-citationTokudome, S., Tokunaga, O., Shimamoto, Y., Miyamoto, Y., Sumida, I., Kikuchi, M., Takeshita, M., Ikeda, T., Fujiwara, K., & Yoshihara, M. (1989) · PubMed · Cited by 123
Estimation of Rate of Incidence of ATL Among ATLV (HTLV-I) Carriers in Kyushu, Japan
TAJIMA, K., & Kuroishi, M. (1985) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a039062 · Cited by 113
Oshima, A., Tsukuma, H., Hiyama, T., Fujimoto, I., Yamano, H., & Tanaka, M. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340607 · Cited by 103
Tajima, K., Kamura, S., Ito, S., Ito, M., Nagatomo, M., Kinoshita, K., & Ikeda, S. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400605 · Cited by 102
Sakuma, K., Takahara, T., Okuda, K., Tsuda, F., & Mayumi, M. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80294-1 · Cited by 74
MORTALITY OF HEPATITIS B POSITIVE BLOOD DONORS IN ENGLAND AND WALES
Hall, A. J., Winter, P. D., & Wright, R. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91976-2 · Cited by 68
Research works printed but not linked: 6
- Beasley R. P., 1982, Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations, Hepatology, 2, 21
- Kinoshita K., 1985, Annual incidence of adult T‐Cell leukemia‐Lymphoma (aTLL) from ATL virus‐Carriers in Nagasaki Prefecture, Nagasaki Igakkai Zasshi, 60, 56
- Kondo T., 1987, Risk of adult T‐Cell leukemia/Lymphoma in HTLV‐I carriers, Lancet, 18
- Kondo T., 1985, Epidemiology of ATLL and preceding stages, Rec. Advanc. RES Res., 25, 156
- Prince A. M., 1982, The risk of development of hepatocellular carcinoma in hepatitis B virus carriers in New York. A preliminary estimate using death‐Records matching, Hepatology, 2, 15
- Tajima K., 1982, Epidemiological analysis of the distribution of antibody to adult T‐Cell leukemia‐Virus‐Associated antigen (aTLA): possible horizontal transmission of adult T‐Cell leukemia virus, Gann, 73, 893
Cited by
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Dougan, M., & Dranoff, G. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132544 · Cited by 607
Cancer and infection: estimates of the attributable fraction in 1990.
Pisani, P., Parkin, D. M., Muñóz, N., & Ferlay, J. (1997) · PubMed · Cited by 448
Human T-lymphotropic virus type I infection
Manns, A., Hisada, M., & Grenade, L. L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09460-4 · Cited by 360
Tajima, K., The T‐ and B‐Cell Malignancy Study Group, & Co‐Authors (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450206 · Cited by 305
Metadata
- Authors
- Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., Inoue, H., Inatsuki, A., Funatsu, T., Yamano, N., Bando, F., Iwao, E., Miyoshi, I., Hinuma, Y., & Hanaoka, M.
- Affiliations
- University of Kochi (JP)
- Shionogi (Japan) (JP)
- Kyoto University (JP)
- Corresponding author
- Kondo, Toshifumi
- ORCID
- Matsumoto, Isao
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1989-06-15
- Volume
- 43
- Issue
- 6
- Pages
- 1061-1064
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1981664147
- Cited by
- 118
- References
- 15
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 5
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- adult T-cell leukemia/lymphoma, HTLV-1 infection, age-standardized incidence rate, cumulative incidence, sex differences, age-specific incidence, seroconversion, seroprevalence, male preponderance, oncogenicity, endemic areas
- MeSH terms
- Age Factors, Carrier State, Humans, Japan, Population Surveillance, Retrospective Studies, Risk Factors, Sex Factors, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Antibodies, HTLV-I Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. https://app.cochat.ai/papers/10.1002/ijc.2910430618
- The paper
- Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., Inoue, H., Inatsuki, A., Funatsu, T., Yamano, N., Bando, F., Iwao, E., Miyoshi, I., Hinuma, Y., & Hanaoka, M. (1989). Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. International Journal of Cancer. https://doi.org/10.1002/ijc.2910430618
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.